Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2025-12-25 @ 12:21 AM
NCT ID:
NCT06285058
Eligibility Criteria:
Inclusion Criteria:
1. Patients' with non-small cell lung cancer, diagnosed through biopsy pathology and clinically classified as stage IB to III;
2. Patients who receive at least two cycles of neoadjuvant immunotherapy combined with chemotherapy induction therapy;
3. According to the IASLC guidelines, postoperative pathological evaluation was performed on the treatment response of the tumor primary lesion and lymph nodes.
Exclusion Criteria:
1. Missing or inadequate quality of CT;
2. Time interval between CT and start of treatment is greater than 1 month;
3. Incomplete clinicopathologic data.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06285058
Study Brief:
Protocol Section:
NCT06285058